Faron de­tails clin­i­cal plans for MDS drug; Cara to seek 's­trate­gic' op­tions

Plus, news about CSL Vi­for, Ake­bia and Pan Can­cer T:

Faron gets FDA go-ahead for stream­lined reg­is­tra­tional path: The com­pa­ny said the reg­u­la­tor “ac­knowl­edged the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER